James Eastham, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses how genomics is going to markedly change how patients are evaluated and treated. Additionally, Dr Eastham highlights the primary focus on developing a multimodal treatment strategy to best manage patients. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.